$52.80
00.00%
Pre-Market: Sep 20, 4:00 PM EDT
15 minutes delayed
Rhythm Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Rhythm Pharmaceuticals using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $-0.55 | $-0.71 | 22.5 % |
Mar 2024 | 2024-05-07 | $-2.35 | $-2.16 | -8.80 % |
Dec 2023 | 2024-02-22 | $-0.70 | $-0.70 | 0.00 % |
Sep 2023 | 2023-11-07 | $-0.76 | $-0.76 | 0.00 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-06 | $29.08M | $29.29M | -0.72 % |
Mar 2024 | 2024-05-07 | $25.97M | $26.90M | -3.47 % |
Dec 2023 | 2024-02-22 | $24.23M | $25.38M | -4.52 % |
Sep 2023 | 2023-11-07 | $22.50M | $22.18M | 1.46 % |
Rhythm Pharmaceuticals (RYTM) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 6, 2024 for Q2.
The Actual EPS was $-0.55, which beat the estimate of $-0.71.
The Actual Revenue was $29.1M, which missed the estimate of $29.3M.
Browse earnings estimates, EPS, and revenue on all stocks.